Sophia Zoungas's Publications

Czernichow S., Kengne Andre, Zoungas Sophia, ADVANCE Collaborative Group Writing Committee, Pillai A., Chalmers J., Neal Bruce
[Abstract] Comparison of various anthropometric indices as predictors of cardiovascular disease in patients with type 2 diabetes
Conference Proceedings
2009
31st Annual Scientific Meeting of the High Blood Pressure Research Council of Australia
Zoungas Sophia, Chalmers J., Patel Anushka
Cardiovascular risk in Type 2 diabetes – reflecting on the ADVANCE study
Journal Article
2009
US Endocrinology
Cass Alan, Navaneethan S., Kang A., Nigwekar S., Zoungas Sophia, Kulshrestha S., Strippoli G., Gallagher M., Jardine M, Perkovic Vlado
[Protocol] Interventions for lowering plasma homocysteine levels in dialysis patients
Journal Article
2009
Cochrane Database of Systematic Reviews
Ninomiya T., Cass Alan, Vasheghani-Farahani A., Sadigh G., Huxley Rachel, Zoungas Sophia, Gallagher M., Jardine M, Perkovic Vlado, Patel Anushka
Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy
Journal Article
2009
Annals of Internal Medicine
Grobbee D., Czernichow S., Kengne Andre, Huxley Rachel, Woodward Mark, Zoungas Sophia, Poulter N., Glasziou P., Harrap S., Hamet P.
Blood pressure variables and cardiovascular risk: new findings from ADVANCE
Journal Article
2009
Hypertension
Grobbee D., Ninomiya T., Cass Alan, de Zeeuw D., Zoungas Sophia, Heerspink H.J., Roberts M., Gallagher M., Jardine M, Perkovic Vlado
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
Journal Article
2009
Lancet
Ninomiya T., Cass Alan, de Galan Bastiaan, Woodward Mark, Zoungas Sophia, ADVANCE Collaborative Group Writing Committee, Pillai A., Marre M., Poulter N., Hamet P.
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
Journal Article
2009
Journal of the American Society of Nephrology
Grobbee D., Travert F., de Galan Bastiaan, Lisheng L., Dufouil C., Woodward Mark, Zoungas Sophia, Pillai A., Poulter N., Anderson Craig
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
Journal Article
2009
Diabetologia
Teede H., Zoungas Sophia, Kerr P., McNeil J., Lui M., McGrath B., Polkinghorne K.
Chronic kidney disease, cardiovascular events and the effect of diabetes: post hoc analyses from ASFAST
Conference Proceedings
2008
Proceedings of the 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology
Zoungas Sophia
The world’s largest study of Type 2 diabetes treatments
Conference Paper
2008
The George Institute Research and Development Advisory Committee (RADAC) Symposium
Zoungas Sophia, Kerr P., McNeil J., McGrath B., Muske C., Polkinghorne K.
Reduced vascular access thrombosis with folic acid: the AFAST randomized placebo controlled trial
Conference Proceedings
2008
Proceedings of the 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology

Sophia Zoungas's Publications

[Abstract] Comparison of various anthropometric indices as predictors of cardiovascular disease in patients with type 2 diabetes

Cardiovascular risk in Type 2 diabetes – reflecting on the ADVANCE study

[Protocol] Interventions for lowering plasma homocysteine levels in dialysis patients

Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy

Blood pressure variables and cardiovascular risk: new findings from ADVANCE

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

Chronic kidney disease, cardiovascular events and the effect of diabetes: post hoc analyses from ASFAST

The world’s largest study of Type 2 diabetes treatments

Reduced vascular access thrombosis with folic acid: the AFAST randomized placebo controlled trial

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country